Live Breaking News & Updates on Elcuity Inc

Stay updated with breaking news from Elcuity inc . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Celcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript

Celcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript March 27, 2024 Celcuity Inc. beats earnings expectations. Reported EPS is $-0.65, expectations were $-0.71. CELC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and welcome to […] ....

Brian Sullivan , Vicky Hahne , Eldon Mayer , Largest Shoe Companies , Chief Commercial Officer , Shoe Companies , Elcuity Inc , Financial Results , Breast Cancer , Fourth Quarter , Maria Yonkoski ,

Celcuity Inc. (NASDAQ:CELC) has caught the attention of institutional investors who hold a sizeable 33% stake

Key Insights Significantly high institutional ownership implies Celcuity's stock price is sensitive to their trading. ....

Brian Sullivan , Vr Adviser , Celcuity Inc , Soleus Capital Management , Institutional Ownership , Elcuity Inc , Nsider Ownership ,

Celcuity to Participate in the 6th Annual Evercore ISI

MINNEAPOLIS, Nov. 22, 2023 (GLOBE NEWSWIRE) Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted. ....

United States , Brian Sullivan , Maria Yonkoski , Vicky Hahne , Celcuity Inc , Annual Evercore , Chief Executive Officer , Nasdaq Celc , Elcuity Inc , Breast Cancer , Prostate Cancer , Viktoria 1 ,

Celcuity To Present at Upcoming Stifel and Jefferies

MINNEAPOLIS, Nov. 01, 2023 (GLOBE NEWSWIRE) Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted. ....

New York , United States , Maria Yonkoski , Vicky Hahne , Brian Sullivan , Celcuity Inc , Chief Executive Officer , Jefferies London Healthcare Conference , Nasdaq Celc , Elcuity Inc , Breast Cancer , Prostate Cancer ,

Celcuity Inc. (NASDAQ:CELC) stock most popular amongst individual investors who own 23%, while private equity firms hold 22%

Key Insights The considerable ownership by individual investors in Celcuity indicates that they collectively have a. ....

Brian Sullivan , Celcuity Inc , Individual Investors , Elcuity Inc , Institutional Investors , Business Strategy , Private Equity Firms ,